Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
Clinical trial NCT01616199 · TERMINATED
Trial details
- NCT number
- NCT01616199
- Sponsor
- Cascadian Therapeutics Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.